1. Therapeutic Focus Areas
  2. Oncology
AbbVie oncology Research building

Oncology research locations

Since 2013, our oncology organization has grown to include world-class experts who share our singular focus of tackling the most widespread and debilitating cancers. We are working to transform care at more than 50 sites around the world, including six oncology research facilities.

Expand All
  • 9,000 employees/researchers
  • Focused on: small molecules & biologics in apoptosis, antibody drug conjugates (ADCs), immuno-oncology (I-O) and T-cell receptor (TCR) therapeutics
  • View the lab here.
  • 215 employees/researchers
  • Focused on: I-O, protein engineering, translation biomarkers and cell based therapies
  • View the lab here.
  • 900 employees/researchers
  • Focused on: kinase inhibitor discovery and development
  • 240 employees/researchers
  • Focused on: cancer stem cell biology, ADCs, biologics discovery and companion diagnostics
  • View the lab here.  
  • 800 employees/researchers
  • Focused on: biologics support for ADCs, I-O and soluble TCR-based therapies
  • View the lab here.
  • 1,000 employees/researchers
  • Focused on: manufacturing small molecules and ADCs, and biologics
  • View the lab here.
A map highlighting abbvie oncology research centers in Germany and the USA